AKOYA BIOSCIENCES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA
1. Akoya's sale to Quanterix is under investigation for adequacy. 2. Shareholders will receive 0.318 shares of Quanterix per Akoya share. 3. Legal firm questions if transaction undervalues Akoya Biosciences.